Paradigm BioDevices Launches VisiCORE ™ – The Clear Choice in Bone Graft Harvesting
CHARLESTON, S.C., July 16, 2024–(BUSINESS WIRE)–Paradigm BioDevices, Inc. announces the launch of VisiCORE, a new bone graft harvesting system for foot and ankle fusion surgeries designed with a clear collection tube with proprietary Graft Retention Technology (GRT)™. The system permits users to see bone graft harvests in real-time, minimizes bone graft loss during collection, reduces the number of passes required to obtain adequate bone graft, and decreases donor site defect.
“It’s awesome to be able to see the work I’m doing,” said OrthoCarolina Foot & Ankle Specialist Carroll Jones, MD. “Until now, I’ve been totally blinded by the tools available to me. VisiCORE is a game-changer. Seeing is believing, and that’s definitely a big improvement for my cases.”
VisiCORE was developed in collaboration with Dr. Jones, and fellow foot & ankle orthopedist, Hodges Davis, MD. “We’re excited to combine our extensive experience in minimally-invasive bone grafting with leading foot & ankle innovators to address challenges in foot and ankle fusion surgeries,” says Mike O’Neill, Paradigm BioDevices’ Founder & President. “Our collaboration has afforded us an opportunity to improve extremity bone grafting capabilities for surgeons and their patients.”
Paradigm is a privately-held Delaware company founded in 1997 to advance minimally-invasive bone graft harvesting innovations. The company pioneered percutaneous access to iliac crest harvesting for spine surgery, and is “the Leader in MIS Bone Graft Harvesting.”
VisiCORE will be exhibited at the AOFAS Meeting in Vancouver, Canada September 11th-13th (Booth # 735), and the NASS Meeting in Chicago September 25th-28th (Booth #4512). VisiCORE, and Graft Retention Technology (GRT) are trademarks of Paradigm BioDevices.
Patents pending. All rights reserved 2024. For more information visit www.paradigmbiodevices.com/products/visicore-bone-harvester
Contacts
